Abstracts Cancer survivors are at significant risk of cardiovascular (CV) morbidity and
mortality; patients with hematologic malignancies have a higher rate of death due to heart …

Cardiovascular disease is a leading cause of death in cancer survivors. It is critical to apply
new predictive and early diagnostic methods in this population, as this can potentially inform …

A right heart tumor can be identified by transthoracic echocardiography during a routine
examination or due to cardiac symptoms. The first step is the assessment by …

Background: Risk stratification strategies for cancer therapeutics-related cardiac dysfunction
(CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability …

Opinion statement Cardio-oncology is going under rapid development in various areas
across an increasing number of provinces in China. However there are still a myriad of …

Cardiovascular diseases are the leading cause of death in women. There is growing
recognition that diagnosis, prognosis, and treatment response differ in women compared …

Cardio-oncology has emerged as a distinct cardiology subspecialty over the last decade.
While many still consider this field to be limited to anthracyclines and heart failure, cardio …

We read with great interest the paper by Aziz-Bose et al 1 on the consensus
recommendations for screening and managing childhood cancer survivors at risk for …

Cardiovascular disease is a leading cause of mortality among cancer survivors globally,
exceeding 370,000 deaths annually, followed by the risk of new tumour development (1) …

Кардиоонкология разработана как относительно новое направление в медицине,
которое фокусируется на профилактике и лечении неблагоприятных сердечно …